Gene therapy for hemophilia represents a groundbreaking advancement in the landscape of hemophilia treatment.This innovative approach, exemplified by Hemgenix, aims to address the root cause of hemophilia by introducing a normal gene to facilitate the production of the essential clotting factor IX.